EverSource Wealth Advisors’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32K | Buy |
74
+12
| +19% | +$214 | ﹤0.01% | 3649 |
|
|
2025
Q1 | $1.11K | Sell |
62
-2
| -3% | -$36 | ﹤0.01% | 3192 |
|
|
2024
Q4 | $1.91K | Buy |
64
+26
| +68% | +$775 | ﹤0.01% | 2727 |
|
|
2024
Q3 | $594 | Hold |
38
| – | – | ﹤0.01% | 2834 |
|
|
2024
Q2 | $865 | Hold |
38
| – | – | ﹤0.01% | 2766 |
|
|
2024
Q1 | $465 | Buy |
+38
| New | +$465 | ﹤0.01% | 2742 |
|
|
2023
Q4 | – | Sell |
-23
| Closed | -$372 | – | 2716 |
|
|
2023
Q3 | $372 | Buy |
23
+17
| +283% | +$275 | ﹤0.01% | 2425 |
|
|
2023
Q2 | $249 | Hold |
6
| – | – | ﹤0.01% | 2409 |
|
|
2023
Q1 | $361 | Hold |
6
| – | – | ﹤0.01% | 2280 |
|
|
2022
Q4 | $440 | Sell |
6
-6
| -50% | -$440 | ﹤0.01% | 2226 |
|
|
2022
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 2079 |
|
|
2022
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 1839 |
|
|
2022
Q1 | $0 | Buy |
+12
| New | – | ﹤0.01% | 1803 |
|